YOHANAN PRESCHEL: Open Payments
NPI 1457391856 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 27 payments from 8 companies in 2025. Trend: 2023 $1,316 · 2024 $865 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $309 |
| Otsuka America Pharmaceutical, Inc. | 5 | $146 |
| Alkermes, Inc. | 3 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| Lundbeck LLC | 2 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
Products named: COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, INVEGA SUSTENNA, ARISTADA, INGREZZA, VIVITROL, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
